The Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute interweaves life sciences, physical sciences, and engineering into the fields of biotechnology and medicine, opening exciting new pathways to innovation and discovery. From complex biological networks to nanoscale assemblies that mimic biological processes, CBIS is a powerhouse of academic and research advancement. More than 200 CBIS scientists and engineers are working here to uncover the molecular basis of biological mechanisms and disease, using biological systems as the basis for new therapeutics, and developing new cellular niches critical in tissue regeneration. More about CBIS
The Center for Biotechnology & Interdisciplinary Studies at Rensselaer
Over Ten Years
- 40 Faculty
- 200 Ph.D.s Granted
- 1,000 Undergrads Trained
- 2,000 Peer-Reviewed Publications
- 30,000 Citations (ISI)
- $130MExternal Grant Funding
News & Events
Edmund F. Palermo, assistant professor of materials science and engineering at Rensselaer Polytechnic Institute, has won a Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF). He will use the five-year, $539,177 award to study “Biomimetic Macromolecules at the Materials-Microbe Interface.”
The graduate programs in engineering at Rensselaer Polytechnic Institute are once again considered among the best in the United States, according to the U.S. News & World Report Best Graduate Schools rankings released last week. For the third year in a row Rensselaer’s graduate engineering programs have been ranked 39th in the nation.
Two doctoral students in biomedical engineering at Rensselaer, Anthony D’Amato and Christopher Johnson, have been awarded New York State Department of Health Spinal Cord Injury Research Board Predoctoral Fellowships.
Research & Constellations
CBIS is conducting groundbreaking research in:
CBIS has four endowed Constellations:
- 150 PhD Students
- 50 Postdoctoral Fellows
- 33 Principal Investigator Laboratories
- 25 Visiting Research Scientists
- 218,000 sq ft modern facility
- 31, 240 sq ft of open research labs
- 13,009 sq ft of support labs
- 27,350 sq ft of core facilities
- 5,830 sq ft conference and seminar space
In the News
Experimental blood test could speed autism diagnosis-U.S. studyMarch 16, 2017 -
Developers of an experimental blood test for autism say it can detect the condition in more than 96 percent of cases and do so across a broad spectrum of patients, potentially allowing for earlier diagnosis, according to a study released on Thursday.
Insight into Pseudomonas aeruginosa survival mechanismNovember 11, 2016 -
The bacterium Pseudomonas aeruginosa can thrive in environments as different as the moist, warm tissue in human lungs, and the dry, nutrient-deprived surface of an office wall. Such adaptability makes it problematic in healthcare.
RPI researchers use nanoparticles to treat influenza in miceNovember 4, 2016 -
Researchers at Rensselaer Polytechnic Institute demonstrated in a paper published last month how they successfully treated immune-compromised mice exposed to the influenza virus with a new nanoparticle drug.
Heparin derived from cattle is equivalent to heparin from pigs, study findsOctober 6, 2016 -
As demand for the widely used blood thinning drug heparin continues to grow, experts worry of possible shortages of the essential medication. Heparin is primarily derived from pigs, and to reduce the risk of shortages, cattle have been proposed as an additional source. A new study by a team of researchers, including corresponding author Robert J. Linhardt, and nine co-authors from Rensselaer Polytechnic Institute. has found that heparin derived from cattle (known as bovine heparin) has equivalent anti-clotting properties to heparin derived from pigs (porcine heparin).
Engineering A New Chemical Communication System Into BacteriaAugust 10, 2015 -
Previously, synthetic biologists had only engineered synthetic quorum-sensing systems in gram-negative bacteria, such as Escherichia coli. But gram-positive bacteria are heavily used in the biotech industry to synthesize enzymes. So Cynthia H. Collins of Rensselaer Polytechnic Institute and colleagues wanted to build systems that would function within these commercially important bacteria.
Albany-area primary care doctors try medical scribesMay 18, 2015 -
When Leslie Palmer went to see her longtime primary care physician, Dr. Paul Barbarotto, earlier this month, there was an extra person in the room ...
Rensselaer Pairs Business Students with Researchers to Aid CommercializationMarch 25, 2015 -
Graduate-level business students at Rensselaer Polytechnic Institute are working with science and engineering faculty to assist researchers in the commercialization process.
Region lands $500K for biomed effortDecember 19, 2014 -
The NY Cap Research Alliance is one of 93 projects in the Albany region receiving a share of $60 million through a state funding competition. The alliance won $500,000 last week to create a capital investment program for biomedical researchers at area colleges and health care organizations.
Who Made That Flavor? Maybe A Genetically Altered MicrobeDecember 11, 2014 -
Take, for instance, chemical compounds called antioxidants. Health-conscious consumers are snapping them up because there's some evidence that these substances repair damaged cells in our body, reducing the risk of cancer and heart problems.
New AAAS Fellows Recognized for Their Contributions to Advancing ScienceDecember 11, 2014 -
Francine Berman, a professor in the computer science department at Rensselaer Polytechnic Institute, was elected a AAAS Fellow "for distinguished contributions to the field of computer science and community leadership in data cyber-infrastructure, digital data preservation, and high performance computing." A former chair of the AAAS section representing Information, Computing, and Communication, Berman was delighted to learn that she has been elected a AAAS Fellow.
Bright idea aims to minimize hospital-acquired infectionsDecember 11, 2014 -
“Individuals can go into a hospital and end up even more sick than when they enter,” said Colleen Costello, a young biomedical engineer, who realized the magnitude of this problem when her grandmother contracted MRSA during a hospital stay. Her company, Vital Vio, is trying to tackle the issue by creating bacteria-killing lights.
Artificial Pancreas Clinical Trial Enabled by NIH GrantNovember 4, 2014 -
An artificial pancreas, the ultimate cure for type 1 diabetes, will be tested in clinical trials as a result of a $1 million National Institutes of Health Grant awarded to Dr. B. Wayne Bequette of Rensselaer Polytechnic Institute to fund research concerning his closed-loop artificial pancreas developed along with colleagues at Stanford University, the University of Colorado, and the University of Virginia. Frequent insulin injections and blood samples may be a thing of the past for recipients of the device.
RPI celebrates 100 years of chemical engineeringOctober 12, 2014 -
One century ago now, the students and faculty helped shape the young field of chemical engineering, using their talents to advance technologies and find new ways to use a range of chemicals ... “The story of chemical engineering at Rensselaer is the story of a major success,” RPI Dean of Engineering Shekhar Garde said. “When you think about chemical engineering, you think about traditional refining and chemical plants and so on, but over the past 100 years, it has evolved into modern discipline.”
Chemical engineering hits century mark at RPIOctober 12, 2014 -
Rensselaer Polytechnic Institute celebrated 100 years of teaching chemical engineering on Thursday with demonstrations by students and faculty on research and discoveries ... Shekhar Garde, dean of the school of engineering at RPI, said the public may perceive chemical engineering to involve mostly oil refineries and chemical plants, but in reality, it involves cutting-edge engineering at the molecular level, involving everything from computer chips to drug development. Chemical engineers are even looking at developing circuitry in cells that could target disease.
RPI biotechnology center celebrates first decadeSeptember 12, 2014 -
TROY >> Rensselaer Polytechnic Institute’s $100 million Center for Biotechnology and Interdisciplinary Studies, now 10 years old, began as a vision shared by RPI President Dr. Shirley Ann Jackson in her 1999 inaugural address.
Decade of growth in RPI biotech unitSeptember 10, 2014 -
It was 15 years ago that newly inauguratedRensselaer Polytechnic Institute PresidentShirley Ann Jackson called for the creation of a biotechnology institute that would draw on multiple disciplines to produce breakthroughs in health and medicine.
Rensselaer's Center for Biotechnology andInterdisciplinary Studies, which opened its doors five years later, will celebrate its 10th anniversary Wednesday.
Scientists use 3D printed tissue to study cellsJuly 24, 2014 -
Scientist Guohao Dai, an assistant professor in the Department of Biomedical Engineering at Rensselaer Polytechnic Institute in the U.S, has won the Faculty Early Career Development Award from the National Science Foundation for his research into making replicated human tissues using 3D printing.